Unity Biotechnology, Inc. Total Long-Term Debt
Unity Biotechnology, Inc. had Total Long-Term Debt of $17.79 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2023-08-08
- 2023-06-30: Long-term Debt $17.79M.
- 2023-03-31: Long-term Debt $20.68M.
- 2022-12-31: Long-term Debt $20.37M.
- 2022-09-30: Long-term Debt $20.04M.
| Period end | Long-term Debt |
|---|---|
| 2023-06-30 | $17.79M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $20.68M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $20.37M 10-K · filed 2023-03-15 |
| 2022-09-30 | $20.04M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $19.76M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $19.37M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $21.46M 10-K · filed 2022-03-15 |
| 2021-09-30 | $25.09M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $24.89M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $24.70M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $24.51M 10-K · filed 2021-03-23 |
| 2020-09-30 | $24.31M 10-Q · filed 2020-11-04 |